Investor desk
Investors should track partnership announcements and pipeline signals from Discovery & Development.
← Back to Events
Tier 1 Global Networking: High NEUROSCIENCE 115 DAYS AWAY
Discovery & Development — 2026 — Hilton San Diego Bayfront, San Diego, USA
Event bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience.
Presentation data updated Apr 17, 2026, 8:37 PM UTC
Why This Event Matters
Event bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience.
Industry impact
Event bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience..
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in US markets.
Regulatory implications
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Investor implications
Investors should track partnership announcements and pipeline signals from Discovery & Development.
Competitive implications
Competitive positioning among neuroscience players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
30 /100 composite
Discovery & Development is a targeted neuroscience forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
neuroscienceNot specifiedPipeline announcements
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Upcoming
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Oct 12, 2026 Upcoming
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Upcoming
Nova editorial monitors confirmed data releases.
- Conference closes Oct 13, 2026 Upcoming
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefEvent bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Competitive intelligence
Competitive positioning among neuroscience players is a core theme — compare with prior editions.
Competitive Landscape
Company map →Competitive positioning among neuroscience players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for Discovery & Development — optimized for research and AI retrieval.
Executive Summary
Event bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience.
Analyst View
Event bringing together experts in biology, chemistry, and technology to support innovation in biopharma, featuring specialized programs in drug discovery, formulation, and neuroscience..
Investor View
Investors should track partnership announcements and pipeline signals from Discovery & Development.
BD View
BD teams should prioritize partnership and licensing conversations at Discovery & Development.
Key Facts
- Event
- Discovery & Development
- Focus
- neuroscience
- Region
- US Americas
- Location
- San Diego, USA
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is Discovery & Development?
Discovery & Development is a neuroscience industry conference for executives, clinical leaders, and investors.
Who attends Discovery & Development?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on neuroscience.
Why is Discovery & Development important?
Discovery & Development influences partnership timing and policy debates affecting neuroscience markets for the next 12–18 months.
Where is Discovery & Development held?
Discovery & Development is held in San Diego, USA.
What should investors watch at Discovery & Development?
Track partnership announcements, pipeline readouts, and management commentary on neuroscience catalysts.
What BD opportunities exist at Discovery & Development?
BD teams use Discovery & Development for licensing, co-development, and vendor selection across neuroscience.
How does Discovery & Development compare with other pharma conferences?
Discovery & Development is a tier-1 global congress for neuroscience — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of Discovery & Development?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.